Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Medtronic, Inc.    

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2017 29 653 M
EBIT 2017 8 303 M
Net income 2017 4 633 M
Debt 2017 22 014 M
Yield 2017 2,36%
Sales 2018 31 017 M
EBIT 2018 9 090 M
Net income 2018 5 510 M
Debt 2018 19 639 M
Yield 2018 2,65%
P/E ratio 2017 21,62
P/E ratio 2018 18,24
EV / Sales2017 4,08x
EV / Sales2018 3,83x
Capitalization 99 043 M
More Financials
Company
Medtronic Plc is engaged in the medical technology-alleviating pain, restoring health, and extending life for millions of people around the world.Its customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care... 
More about the company
Surperformance© ratings of Medtronic, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on MEDTRONIC, INC.
12:01p MEDTRONIC : Endurant(TM) II/IIs Stent Graft System Receives CE Mark for Use with..
12/05 MEDTRONIC : Management's Discussion and Analysis of Financial Condition and Resu..
12/05 MEDTRONIC : The Joint National Committee for Language and the National Council f..
12/02 MEDTRONIC PLC : Change in Directors or Principal Officers (form 8-K)
12/02 MEDTRONIC : Announces Reimbursement Approval and Launch of CoreValve Evolut R Sy..
12/02 MEDTRONIC : Announces Reimbursement Approval and Launch of CoreValve(TM) Evolut(..
12/01 MEDTRONIC : Collagen Matrix, Inc. Names Oystein Valberg as Chief Financial Offic..
12/01 MEDTRONIC : Announces Reimbursement Approval and Launch of CoreValve(TM) Evolut(..
12/01 MEDTRONIC PLC : Post Earnings Coverage as Medtronic Adjusted EPS Grows 15%
12/01 MEDTRONIC : Contract award - 99-- defibrillator-medtronic
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
11/15 Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
11/09 Trump stand on AT&T/Time Warner not indicative of M&A policy - analysts
11/03 SMITH & NEPHEW : revenue up two percent, at bottom end of forecasts
10/31DJZIMMER BIOMET : Cuts Forecasts -- Update
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
2015 DIVIDEND INCOME UPDATE : January 2015
2015 FDA clears Medtronic transcatheter heart valve
2015 Dividend Aristocrats And A Fundamental Principle Of Dividend Growth Investing
2015 Boston Scientific Awaits Court Decision
2015 The DGI 'Factual 48' Versus 'The Favored 44'
Advertisement
Chart MEDTRONIC, INC.
Duration : Period :
Medtronic, Inc. Technical Analysis Chart | US5850551061 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 85,5 $
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Omar S. Ishrak Chairman & Chief Executive Officer
Gary Lee Ellis EVP-Global Operations & Information Technology
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Richard E. Kuntz Chief Scientific, Clinical & Regulatory Officer
Richard H. Anderson Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC, INC.0.78%99 043
MEDTRONIC PLC-6.83%99 043
BAXTER INTERNATIONAL I..15.36%23 873
ZIMMER BIOMET HOLDINGS..-1.13%20 316
C R BARD INC10.96%15 456
HOYA CORPORATION-10.23%15 066
More Results